These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8004848)

  • 21. Nephrocalcinosis, hyperparathyroidism, and renal failure in familial hypophosphatemic rickets.
    Alon U; Lovell HB; Donaldson DL
    Clin Pediatr (Phila); 1992 Mar; 31(3):180-3. PubMed ID: 1547591
    [No Abstract]   [Full Text] [Related]  

  • 22. Nephrocalcinosis and its relationship to treatment of hereditary rickets.
    Goodyer PR; Kronick JB; Jequier S; Reade TM; Scriver CR
    J Pediatr; 1987 Nov; 111(5):700-4. PubMed ID: 2822887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperoxaluria is not a cause of nephrocalcinosis in phosphate-treated patients with hereditary hypophosphatemic rickets.
    Tieder M; Blonder J; Strauss S; Shaked U; Maor J; Gabizon D; Manor H; Sela BA
    Nephron; 1993; 64(4):526-31. PubMed ID: 8396209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A trial of growth hormone therapy in well-controlled hypophosphataemic rickets.
    Cameron FJ; Sochett EB; Daneman A; Kooh SW
    Clin Endocrinol (Oxf); 1999 May; 50(5):577-82. PubMed ID: 10468922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary supersaturation of calcium oxalate and phosphate in patients with X-linked hypophosphatemic rickets and in healthy schoolchildren.
    Patzer L; van't Hoff W; Shah V; Hallson P; Kasidas GP; Samuell C; de Bruyn R; Barratt TM; Dillon MJ
    J Pediatr; 1999 Nov; 135(5):611-7. PubMed ID: 10547250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of phosphate supplementation on linear growth in children with X-linked hypophosphatemia.
    Seikaly MG; Browne RH; Baum M
    Pediatrics; 1994 Oct; 94(4 Pt 1):478-81. PubMed ID: 7936855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia.
    Glorieux FH; Scriver CR; Reade TM; Goldman H; Roseborough A
    N Engl J Med; 1972 Sep; 287(10):481-7. PubMed ID: 4340235
    [No Abstract]   [Full Text] [Related]  

  • 28. X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy.
    Petersen DJ; Boniface AM; Schranck FW; Rupich RC; Whyte MP
    J Bone Miner Res; 1992 Jun; 7(6):583-97. PubMed ID: 1414477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.
    Sullivan W; Carpenter T; Glorieux F; Travers R; Insogna K
    J Clin Endocrinol Metab; 1992 Sep; 75(3):879-85. PubMed ID: 1517380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. X-linked hypophosphatemia: normal renal function despite medullary nephrocalcinosis 25 years after transient vitamin D2-induced renal azotemia.
    Eddy MC; McAlister WH; Whyte MP
    Bone; 1997 Dec; 21(6):515-20. PubMed ID: 9430241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
    Glorieux FH; Marie PJ; Pettifor JM; Delvin EE
    N Engl J Med; 1980 Oct; 303(18):1023-31. PubMed ID: 6252463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rickets, the continuing challenge.
    Glorieux FH
    N Engl J Med; 1991 Dec; 325(26):1875-7. PubMed ID: 1660099
    [No Abstract]   [Full Text] [Related]  

  • 33. Growth hormone therapy in hypophosphatemic rickets.
    Wilson DM; Lee PD; Morris AH; Reiter EO; Gertner JM; Marcus R; Quarmby VE; Rosenfeld RG
    Am J Dis Child; 1991 Oct; 145(10):1165-70. PubMed ID: 1928011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tertiary hyperparathyroidism during the treatment of familial hypophosphatemic rickets].
    Moreno Molina JA; López Siguero JP; Bueno Fernández A; Martínez-Aedo Ollero MJ; Martínez Valverde A
    An Esp Pediatr; 1996 Aug; 45(2):193-5. PubMed ID: 8967654
    [No Abstract]   [Full Text] [Related]  

  • 35. The Impact of Hypoparathyroidism Treatment on the Kidney in Children: Long-Term Retrospective Follow-Up Study.
    Levy I; Licht C; Daneman A; Sochett E; Harrington J
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4106-13. PubMed ID: 26323021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythrocytosis in hypophosphatemic rickets: irreversible complication due to nephrocalcinosis after vitamin D and phosphate therapy.
    Okazaki R; Matsumoto T; Harada S; Fukomoto S; Motokura T; Ogata E
    Jpn J Med; 1991; 30(6):545-7. PubMed ID: 1665879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early treatment of familial hypophosphataemic rickets.
    Roza M; Miguel MA; Galbe M; Mejido L; Mencia C
    Arch Dis Child; 1983 Dec; 58(12):1020-2. PubMed ID: 6689262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets.
    Mäkitie O; Kooh SW; Sochett E
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):163-8. PubMed ID: 12580931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation.
    Kruse K; Woelfel D; Strom TM
    Horm Res; 2001; 55(6):305-8. PubMed ID: 11805436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. More evidence for hyperoxaluria in phosphate-treated X-linked familial hypophosphataemic rickets.
    Schönaue E; Kruse K; Böhles HJ; Sewell AC
    Eur J Pediatr; 1992 May; 151(5):390. PubMed ID: 1396903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.